NEW YORK, March 22 – Fiber optics giant Corning, which has recently secured key partnerships in its effort to mass-produce microarrays, is planning a full-scale commercial launch of its human microarray in June, the company said.

This launch comprises the first major commercialization step in Corning’s microarray marketing plans. “Our intention is to have genome-wide coverage across major organisms of interest,” for the arrays, said John Lubniewski, manager of sales and marketing for Corning Microarray Technologies. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The ancestors of the Arizona bark scorpion and other scorpions and spiders underwent whole-genome duplication, KJZZ reports.

A cryptographic approach could help researchers keep genomic data private while researchers analyze it, Scientific American reports.

Andy Page, the former president of 23andMe, has joined a diabetes-management startup, according to CNBC.

In Cell this week: regulatory changes in pancreatic cancer, metabolic shifts in Alzheimer's disease, and more.